FBLG

NASDAQStock

FibroBiologics, Inc. Common Stock

$0.31-0.03 (-8.26%)

52-Week Range

$0.22

$1.38

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

-0.67

Volume

767.7K

Avg Volume

1.3M

Performance

+38.25%

+29.32%

-36.93%

YTD

+41.77%

-66.66%

-98.83%

Price Chart

ETF Exposure

FBLG is held by 8 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
IWC	iShares Micro-Cap ETF	0.00%	124,751	$42K	$1.27B	0.60%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	39	$17	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	1,401	$629	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	6	$3	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	797,931	$265K	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	4,196	$2K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	361	$162	$1.29B	0.17%
VXF	Vanguard Extended Market ETF	0.00%	280,059	$93K	$84.10B	0.05%

About FBLG ETF Exposure

FibroBiologics, Inc. Common Stock (FBLG) is held by 8 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $0.31. Investors can gain exposure to FBLG through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold FBLG, sorted by portfolio weight.